Peter Höglund (Former)
191 – 200 of 202
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2002
-
Mark
Descriptive study and pharmacotherapeutic intervention in patients with epilepsy or Parkinson's disease at nursing homes in southern Sweden.
(
- Contribution to journal › Article
- 2001
-
Mark
A new liposomal liver-specific contrast agent for CT: first human phase-I clinical trial assessing efficacy and safety
(
- Contribution to journal › Article
-
Mark
Clinical pharmacology of thalidomide
(
- Contribution to journal › Article
- 2000
-
Mark
Elimination of S100B and renal function after cardiac surgery
(
- Contribution to journal › Article
- 1998
-
Mark
Human pharmacokinetics and modeling of the concentration-attenuation relationship of a new liposomal liver-specific contrast agent for CT
(
- Contribution to journal › Article
-
Mark
New liposomal liver-specific contrast agent for CT: first human phase I clinical trial assessing efficacy and safety
(
- Contribution to journal › Article
- 1989
-
Mark
Pharmacokinetic comparison of two models of endocarditis prophylaxis with amoxycillin
(
- Contribution to journal › Article
- 1987
-
Mark
The interaction of erythromycin with theophylline
(
- Contribution to journal › Article
-
Mark
Interaction between isoniazid and theophylline
(
- Contribution to journal › Article
-
Mark
Liquid chromatographic determination of diltiazem and its metabolites using trans isomers as internal standards, with dynamic modification of the solid phase by addition of an amine to the mobile phase
(
- Contribution to journal › Article